Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Role of Tumor Necrosis Factor-Alpha in the Pathogenesis and Treatment of Nonalcoholic Fatty Liver Disease
Ilias D. Vachliotis, Stergios A. Pοlyzos
Current Obesity Reports (2023) Vol. 12, Iss. 3, pp. 191-206
Open Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Emerging advanced approaches for diagnosis and inhibition of liver fibrogenesis
Tamer A. Addissouky, Majeed M. A. Ali, Ibrahim El Tantawy El Sayed, et al.
The Egyptian Journal of Internal Medicine (2024) Vol. 36, Iss. 1
Open Access | Times Cited: 9
Role of Glucocorticoids in Metabolic Dysfunction-Associated Steatotic Liver Disease
Stergios A. Pοlyzos, Giovanni Targher
Current Obesity Reports (2024) Vol. 13, Iss. 2, pp. 242-255
Open Access | Times Cited: 8
ACLY as a modulator of liver cell functions and its role in Metabolic Dysfunction-Associated Steatohepatitis
Paolo Convertini, Anna Santarsiero, Simona Todisco, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 17
AdipoRon and ADP355, adiponectin receptor agonists, in Metabolic-associated Fatty Liver Disease (MAFLD) and Nonalcoholic Steatohepatitis (NASH): A systematic review
Sandra Maria Barbalho, Nahúm Méndez‐Sánchez, Lucas Fornari Laurindo
Biochemical Pharmacology (2023) Vol. 218, pp. 115871-115871
Closed Access | Times Cited: 16
Long-term intermittent hypoxia in mice induces inflammatory pathways implicated in sleep apnea and steatohepatitis in humans
Jonathan Gaucher, Emilie Montellier, Guillaume Vial, et al.
iScience (2024) Vol. 27, Iss. 2, pp. 108837-108837
Open Access | Times Cited: 7
Zinc ions regulate mitochondrial quality control in neurons under oxidative stress and reduce PANoptosis in spinal cord injury models via the Lgals3-Bax pathway
Mingyu Bai, Yang Cui, Zelin Sang, et al.
Free Radical Biology and Medicine (2024) Vol. 221, pp. 169-180
Closed Access | Times Cited: 5
The multiple mechanisms and therapeutic significance of rutin in metabolic dysfunction-associated fatty liver disease (MAFLD)
Qianzhuo Wang, Yingjuan Zhang, Ruiling Lu, et al.
Fitoterapia (2024) Vol. 178, pp. 106178-106178
Closed Access | Times Cited: 5
Cytokines as Key Players in Obesity Low Grade Inflammation and Related Complications
Daniel Ejim Uti, Item Justin Atangwho, Wilson Achu Omang, et al.
Obesity Medicine (2025), pp. 100585-100585
Closed Access
The effects of prenatal administration of tumor necrosis factor-α on osteocalcin and RANK expression in newborn mice
Mohsen Basiri, Farhad Mortezazadeh, Seyed Noureddin Nematollahi‐Mahani, et al.
Journal of Molecular Histology (2025) Vol. 56, Iss. 2
Closed Access
The emerging role of deubiquitylating enzyme USP21 as a potential therapeutic target in cancer
Zhen-Yuan Shi, Changyun Li, Ru-Yi Chen, et al.
Bioorganic Chemistry (2024) Vol. 147, pp. 107400-107400
Closed Access | Times Cited: 4
The Improvement Effects of Weizmannia coagulans BC99 on Liver Function and Gut Microbiota of Long-Term Alcohol Drinkers: A Randomized Double-Blind Clinical Trial
Jie Zhang, C. Li, Ming Duan, et al.
Nutrients (2025) Vol. 17, Iss. 2, pp. 320-320
Open Access
Comorbid flow non-alcoholic fatty liver disease and osteoporosis
Л. А. Фомина
Medical alphabet (2025), Iss. 34, pp. 42-46
Closed Access
Decoding Health: Exploring Essential Biomarkers Linked to Metabolic Dysfunction-Associated Steatohepatitis and Type 2 Diabetes Mellitus
Sulagna Mukherjee, Seung‐Soon Im
Biomedicines (2025) Vol. 13, Iss. 2, pp. 359-359
Open Access
TACE inhibition: a promising therapeutic intervention against AATF‐mediated steatohepatitis to hepatocarcinogenesis
Akshatha N. Srinivas, Diwakar Suresh, Prashant M. Vishwanath, et al.
Molecular Oncology (2024) Vol. 18, Iss. 8, pp. 1940-1957
Open Access | Times Cited: 3
Potential Therapeutic Strategies in the Treatment of Metabolic-Associated Fatty Liver Disease
Aleksandra Bołdys, Łukasz Bułdak, Mateusz Maligłówka, et al.
Medicina (2023) Vol. 59, Iss. 10, pp. 1789-1789
Open Access | Times Cited: 9
Probiotics ameliorate endocrine disorders via modulating inflammatory pathways: a systematic review
Marzieh Nemati, Bahareh Ebrahimi, Nima Montazeri‐Najafabady
Genes & Nutrition (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 3
Animal studies on glucagon-like peptide-1 receptor agonists and related polyagonists in nonalcoholic fatty liver disease
Chara Tsiampali, Ilias D. Vachliotis, A. Goulas, et al.
HORMONES (2024) Vol. 23, Iss. 4, pp. 611-619
Open Access | Times Cited: 3
Sex differences in Murine MASH evoked by a Fructose-Palmitate-Cholesterol-Enriched Diet
Lakshmi Arivazhagan, Sofie Y. N. Delbare, Robin A. Wilson, et al.
JHEP Reports (2024) Vol. 7, Iss. 2, pp. 101222-101222
Open Access | Times Cited: 3
Identification of key genes involved in the alleviative effects of Polysaccharide of Atractylodes macrocephala Koidz on high-fat diet-induced nonalcoholic fatty liver disease in mice
X Chen, Shuzhan Yang, Haiqiong Yu, et al.
Journal of Functional Foods (2024) Vol. 116, pp. 106201-106201
Open Access | Times Cited: 2
Integration of Transcriptomics and Lipidomics Profiling to Reveal the Therapeutic Mechanism Underlying Ramulus mori (Sangzhi) Alkaloids for the Treatment of Liver Lipid Metabolic Disturbance in High-Fat-Diet/Streptozotocin-Induced Diabetic Mice
Fan Wang, Sai-Jun Xu, Fan Ye, et al.
Nutrients (2023) Vol. 15, Iss. 18, pp. 3914-3914
Open Access | Times Cited: 6
Tumor Necrosis Factor-Alpha and Adiponectin in Nonalcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma
Ilias D. Vachliotis, Ioannis Valsamidis, Stergios A. Pοlyzos
Cancers (2023) Vol. 15, Iss. 21, pp. 5306-5306
Open Access | Times Cited: 5
Clinical improvement effect of regulating gut microbiota on metabolic dysfunction-associated steatotic liver disease: systematic review and meta-analysis of randomized controlled trials
Wu Juan, Xiaoyang Chen, Jun Qian, et al.
Clinics and Research in Hepatology and Gastroenterology (2024) Vol. 48, Iss. 7, pp. 102397-102397
Closed Access | Times Cited: 1
Immune system dysregulation in the pathogenesis of non-alcoholic steatohepatitis: unveiling the critical role of T and B lymphocytes
Merve Çebi, Yusuf Yılmaz
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Differential effects of low or high-fat dairy and fat derived from dairy products on MASLD
Oren Tirosh, Michal Verman, Dana Ivancovsky‐Wajcman, et al.
JHEP Reports (2024) Vol. 6, Iss. 11, pp. 101194-101194
Open Access | Times Cited: 1
The role of inflammation induced by necroptosis in the development of fibrosis and liver cancer in novel knockin mouse models fed a western diet
Ramasamy Selvarani, Hai Thanh Nguyen, N. Pazhanivel, et al.
GeroScience (2024)
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top